Mast cell membrane targets involved in degranulation

Mast cell membrane targets involved in degranulation represent a heterogeneous group of surface proteins that orchestrate the rapid release of preformed inflammatory mediators. The primary driver of classical allergic responses is the high-affinity IgE receptor (FcεRI), which initiates a signaling cascade upon cross-linking of IgE by allergens (Galli et al., 2008, Nature). Other critical receptors include MRGPRX2, which facilitates non-IgE-mediated degranulation in response to various drugs and peptides, and the KIT receptor tyrosine kinase (CD117), which is vital for mast cell development and survival (McNeil et al., 2015, Nature; Metcalfe, 2008, J Allergy Clin Immunol). Inhibitory receptors such as Siglec-8 and CD200R provide essential negative feedback to prevent excessive activation (O'Sullivan et al., 2018, J Allergy Clin Immunol). These targets are central to the pathophysiology of allergic rhinitis, asthma, chronic urticaria, and systemic mastocytosis. Pharmacological intervention focuses on blocking activating signals, such as with the IgE-blocker Omalizumab, or enhancing inhibitory pathways to mitigate the systemic effects of histamine, proteases, and cytokines released during degranulation (Stone et al., 2010, JAMA). Additionally, mast cell stabilizers like cromolyn sodium are used to prevent the degranulation process itself, although their exact molecular targets on the membrane remain a subject of ongoing research (Finn & Henderson, 2011, J Allergy Clin Immunol).

Other names

Mast cell activation receptorsMast cell degranulation proteinsMast cell surface receptorsPro-degranulation membrane proteins

Inhibition of IgE binding to FcεRI, inhibition of KIT kinase signaling, agonism of inhibitory Siglec receptors, and stabilization of the mast cell membrane to prevent mediator release.